Nicole E Rich1,2, Caitlin C Murphy1,2,3, Adam C Yopp2,4, Jasmin Tiro2,3, Jorge A Marrero1, Amit G Singal1,2,3. 1. Division of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA. 2. Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. 3. Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA. 4. Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
Abstract
BACKGROUND: Although sex disparities in hepatocellular carcinoma (HCC) incidence have been well described, there are limited data examining sex disparities in HCC prognosis. AIM: To characterise sex differences in HCC presentation and prognosis. METHODS: We performed a retrospective study of consecutive patients (n = 1110, 23.5% women) diagnosed with HCC between 2008 and 2017 at two US health systems. We used Cox proportional hazard and multivariable logistic regression models to identify factors associated with overall survival, early tumour detection and response to HCC treatment (per the modified Response Evaluation Criteria in Solid Tumors [mRECIST] criteria). RESULTS: Women were older at HCC diagnosis (mean 62.5 vs 59.2 years, P < 0.001) and had a higher proportion of early-stage tumours (53.1% vs 43.7% Barcelona Clinic Liver Cancer [BCLC] stage 0/A, P = 0.04), but similar liver function compared to men (49.2% vs 47.1% Child Pugh A, P = 0.27). In univariable analysis, women had significantly better overall survival than men (median 17.1 vs 12.0 months, P = 0.02). When stratified by age, younger (<65 years) women had better overall survival than men (18.3 vs 11.2 months, P = 0.02); however, older (≥65 years) women and men had similar overall survival (15.5 vs 15.7 months, P = 0.45). In multivariable analysis, female sex was independently associated with lower mortality after adjusting for age, race/ethnicity, alpha-fetoprotein, BCLC stage, Albumin-Bilirubin grade and Child Pugh score (hazard ratio [HR] 0.82, 95% confidence interval [CI] 0.68-0.98). In secondary analyses, female sex was independently associated with early tumour detection (odds ratio [OR] 1.46, 95% CI 1.05-2.02) and response to first HCC treatment (OR 1.72, 95% CI 1.18-2.53) after adjusting for the same covariates. CONCLUSION: In a large cohort of patients with HCC, women had significantly better prognosis than men.
BACKGROUND: Although sex disparities in hepatocellular carcinoma (HCC) incidence have been well described, there are limited data examining sex disparities in HCC prognosis. AIM: To characterise sex differences in HCC presentation and prognosis. METHODS: We performed a retrospective study of consecutive patients (n = 1110, 23.5% women) diagnosed with HCC between 2008 and 2017 at two US health systems. We used Cox proportional hazard and multivariable logistic regression models to identify factors associated with overall survival, early tumour detection and response to HCC treatment (per the modified Response Evaluation Criteria in Solid Tumors [mRECIST] criteria). RESULTS: Women were older at HCC diagnosis (mean 62.5 vs 59.2 years, P < 0.001) and had a higher proportion of early-stage tumours (53.1% vs 43.7% Barcelona Clinic Liver Cancer [BCLC] stage 0/A, P = 0.04), but similar liver function compared to men (49.2% vs 47.1% Child Pugh A, P = 0.27). In univariable analysis, women had significantly better overall survival than men (median 17.1 vs 12.0 months, P = 0.02). When stratified by age, younger (<65 years) women had better overall survival than men (18.3 vs 11.2 months, P = 0.02); however, older (≥65 years) women and men had similar overall survival (15.5 vs 15.7 months, P = 0.45). In multivariable analysis, female sex was independently associated with lower mortality after adjusting for age, race/ethnicity, alpha-fetoprotein, BCLC stage, Albumin-Bilirubin grade and Child Pugh score (hazard ratio [HR] 0.82, 95% confidence interval [CI] 0.68-0.98). In secondary analyses, female sex was independently associated with early tumour detection (odds ratio [OR] 1.46, 95% CI 1.05-2.02) and response to first HCC treatment (OR 1.72, 95% CI 1.18-2.53) after adjusting for the same covariates. CONCLUSION: In a large cohort of patients with HCC, women had significantly better prognosis than men.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Amit G Singal; Adam Yopp; Celette S Skinner; Milton Packer; William M Lee; Jasmin A Tiro Journal: J Gen Intern Med Date: 2012-01-04 Impact factor: 5.128
Authors: Chi Ming Lam; Jamy L Yong; Annie O Chan; Kelvin K Ng; Ronnie T Poon; Chi Leung Liu; Chung Mau Lo; Sheung Tat Fan Journal: J Clin Gastroenterol Date: 2005-07 Impact factor: 3.062
Authors: Manal M Hassan; Gehan Botrus; Reham Abdel-Wahab; Robert A Wolff; Donghui Li; David Tweardy; Alexandria T Phan; Ernest Hawk; Milind Javle; Ju-Seog Lee; Harrys A Torres; Asif Rashid; Renato Lenzi; Hesham M Hassabo; Yasmin Abaza; Ahmed S Shalaby; Sahin Lacin; Jeffrey Morris; Yehuda Z Patt; Christopher I Amos; Saira A Khaderi; John A Goss; Prasun K Jalal; Ahmed O Kaseb Journal: Clin Gastroenterol Hepatol Date: 2017-06-01 Impact factor: 11.382
Authors: Maya R Ladenheim; Nathan G Kim; Pauline Nguyen; An Le; Marcia L Stefanick; Gabriel Garcia; Mindie H Nguyen Journal: BMJ Open Gastroenterol Date: 2016-07-25
Authors: Nicole E Rich; Binu V John; Neehar D Parikh; Ian Rowe; Neil Mehta; Gaurav Khatri; Smitha M Thomas; Munazza Anis; Mishal Mendiratta-Lala; Christopher Hernandez; Mobolaji Odewole; Latha T Sundaram; Venkata R Konjeti; Shishir Shetty; Tahir Shah; Hao Zhu; Adam C Yopp; Yujin Hoshida; Francis Y Yao; Jorge A Marrero; Amit G Singal Journal: Hepatology Date: 2020-10-25 Impact factor: 17.425
Authors: Nicole E Rich; Samuel Phen; Nirali Desai; Sukul Mittal; Adam C Yopp; Ju Dong Yang; Jorge A Marrero; Puneeth Iyengar; Rodney E Infante; Amit G Singal Journal: Clin Gastroenterol Hepatol Date: 2021-09-20 Impact factor: 13.576
Authors: Yu Lin; Jianhui Zhu; Jie Zhang; Jianliang Dai; Suyu Liu; Ana Arroyo; Marissa Rose; Amit G Singal; Neehar D Parikh; David M Lubman Journal: ACS Omega Date: 2022-06-22
Authors: Jenny Jan; Azeez Osho; Caitlin C Murphy; Carolyn M Mazure; Amit G Singal; Nicole E Rich Journal: Gastroenterology Date: 2022-03-12 Impact factor: 33.883
Authors: Yu Lin; Jianhui Zhu; Lingyun Pan; Jie Zhang; Zhijing Tan; Jocelyn Olivares; Amit G Singal; Neehar D Parikh; David M Lubman Journal: J Proteome Res Date: 2021-04-30 Impact factor: 5.370
Authors: Nicole E Rich; Christian Carr; Adam C Yopp; Jorge A Marrero; Amit G Singal Journal: Clin Gastroenterol Hepatol Date: 2020-12-30 Impact factor: 11.382